Literature DB >> 1593888

The influence of hepatic artery ligation and of vasopressin on liver tumour blood flow in rats.

P Naredi1, P Lindnér, S B Holmberg, R Söderberg, G Carlsson, B Gustavsson, L Jacobsson, L Hafström.   

Abstract

The blood flow in an experimental adenocarcinoma in the rat liver was determined with the 133Xe-washout technique before and after hepatic artery ligation (HAL). There was an initial reduction of the washout of 50%. This was further reduced after 1 day by 50%, which was maintained for 7 days. Seven days after HAL or sham procedures the 133Xe-washout was of similar magnitude in the liver tumours, although after the sham procedure the tumours were larger (3.4 g vs. 1.5 g). The estimated tumour blood flow was then approximately 0.04 ml x min-1 x g-1. The influence on normal liver parenchyma of HAL was a reduction at 30 minutes, which was maintained for 7 days. Postacton--a synthetic vasopressin--did not influence the 133Xe-washout in normal liver parenchyma in non-tumour, as well as in tumour-bearing animals. There was no influence of Postacton on the 133Xe-washout in the liver tumours. Thirty minutes after HAL Postacton gave a reduction of blood flow in normal liver parenchyma of tumour-bearing animals, which is thus only from the portal vein. In tumours Postacton did not significantly reduce the tumour blood flow immediately after HAL.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1593888     DOI: 10.1002/jso.2930500203

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  1 in total

1.  Noninvasive quantitative measurement of tissue blood flow in hepatocellular carcinoma using xenon-enhanced computed tomography.

Authors:  Junzo Shimizu; Hiroshi Oka; Keizo Dono; Masato Sakon; Manabu Takamura; Takamichi Murakami; Shouho Hayashi; Hiroaki Nagano; Shoji Nakamori; Koji Umeshita; Shigeru Sase; Mitsukazu Gotoh; Kenichi Wakasa; Hironobu Nakamura; Morito Monden
Journal:  Dig Dis Sci       Date:  2003-08       Impact factor: 3.199

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.